Coordinated by Lewis Medix – Delivered by LIV Hospital
At Lewis Medix, our mission is simple yet powerful: to empower clients with access to world-class healthcare options. We don’t perform treatments; our specialty is supporting our clients, and we always want the best for our clients – therefore, we have chosen to partner with Liv Hospital Regenerative Medicine and Stem Cell Center in Istanbul, Türkiye’s pioneering hospital-based facility for personalized stem cell therapy.
Through this partnership, Lewis Medix ensures that clients seeking advanced regenerative medicine have a seamless, supported journey — from initial consultation to treatment coordination and recovery. Liv Hospital provides the science and clinical expertise, while Lewis Medix provides the guidance, logistics, and advocacy to make the process smooth and transparent.
Why Türkiye for Stem Cell Therapy?
Türkiye has become a global hub for regenerative medicine and medical tourism, offering:
-
- Internationally accredited hospitals (JCI Accreditation) and GMP-certified laboratories
-
- Highly trained specialists collaborating with global research institutions
-
- Affordable, patient-centered care without compromising quality
To date, stem cell therapy is not always readily available in many countries. For clients seeking advanced treatments, Türkiye combines cutting-edge science with compassionate care.
What Stem Cell Therapy Offers
Stem cells are unique in their ability to repair, regenerate, and restore. Applications include:
-
- Orthopedics: cartilage repair, tendon injuries, osteoarthritis
-
- Neurology: spinal cord injuries, stroke rehabilitation, ALS
-
- Pulmonology: COPD, cystic fibrosis, post-COVID lung damage
-
- Cardiology: ischemic heart disease, erectile dysfunction
-
- Aesthetics: skin rejuvenation, hair restoration
Our Partnership with Liv Hospital
Through our collaboration with Liv Hospital, Lewis Medix supports clients every step of the way:
-
- Personalized treatment pathways designed with Liv’s regenerative medicine specialists
-
- Evidence-based protocols aligned with international research standards
-
- Comprehensive care coordination, from consultation to recovery
Liv Hospital’s research emphasizes the safe and effective clinical translation of stem cells into regenerative medicine applications — a mission we proudly believe in.
Why Choose Lewis Medix?
Navigating international healthcare can feel overwhelming. At Lewis Medix, we make it seamless:
-
- We handle logistics and coordination so clients can focus on healing
-
- We ensure treatments meet ethical and scientific standards
-
- We provide personalized, professional on-site support in Istanbul for all of our clients
-
- We empower clients with transparent information and ongoing support
-
- We coordinate after-care with your family physician and medical team at home to ensure seamless support for your healing and well-being
Conclusion
Stem cell therapy in Türkiye represents hope, innovation, and transformation. With Lewis Medix and Liv Hospital working together in collaboration, clients gain access to world-class regenerative medicine — delivered with compassion, clarity, and confidence.
Reference: Liv Hospital Regenerative Medicine and Stem Cell Center, Istanbul — internationally accredited research and clinical applications in regenerative medicine.
For more information on stem cell therapy in Turkiye – check out this research article:
Breakthrough in Stem Cell Therapy from Turkey
A recent peer‑reviewed study published in Frontiers in Medicine highlights the success of mesenchymal stem cell (MSC) therapy for stroke patients in Istanbul. Conducted under the approval of the Turkish Ministry of Health Stem Cell Commission, the research followed patients for 12 months after receiving umbilical cord–derived MSCs.
Patients showed encouraging improvements in recovery and rehabilitation Treatment was delivered safely in accredited clinical settings Findings underscore Turkey’s growing role in advanced stem cell therapies
This study adds to the global evidence that stem cell therapy can offer new hope for patients who miss the standard treatment window for stroke.
Read the full article here: Frontiers in Medicine –
https://lnkd.in/gsUGKaEQ
